HUT69785A - Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation - Google Patents

Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation Download PDF

Info

Publication number
HUT69785A
HUT69785A HU9401824A HU9401824A HUT69785A HU T69785 A HUT69785 A HU T69785A HU 9401824 A HU9401824 A HU 9401824A HU 9401824 A HU9401824 A HU 9401824A HU T69785 A HUT69785 A HU T69785A
Authority
HU
Hungary
Prior art keywords
protein
molecular weight
agent
pharmaceutical composition
protective agent
Prior art date
Application number
HU9401824A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9401824D0 (en
Inventor
Gordon L Amidon
Glen D Leesman
Patrick J Sinko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9401824D0 publication Critical patent/HU9401824D0/hu
Publication of HUT69785A publication Critical patent/HUT69785A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HU9401824A 1991-12-18 1992-11-09 Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation HUT69785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81059391A 1991-12-18 1991-12-18

Publications (2)

Publication Number Publication Date
HU9401824D0 HU9401824D0 (en) 1994-09-28
HUT69785A true HUT69785A (en) 1995-09-28

Family

ID=25204183

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401824A HUT69785A (en) 1991-12-18 1992-11-09 Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation

Country Status (12)

Country Link
EP (1) EP0617626A1 (pt)
JP (1) JPH06510796A (pt)
AU (1) AU3058392A (pt)
CA (1) CA2125400A1 (pt)
FI (1) FI942938A7 (pt)
HU (1) HUT69785A (pt)
IL (1) IL104048A0 (pt)
MX (1) MX9207407A (pt)
NO (1) NO942323D0 (pt)
PT (1) PT101135A (pt)
WO (1) WO1993011799A1 (pt)
ZA (1) ZA929761B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145763A1 (en) * 1992-10-02 1994-04-14 William J. Curatolo Pharmaceutical compositions containing nonionic surfactants
AU7273494A (en) * 1993-09-01 1995-03-22 Pfizer Inc. Pharmaceutical compositions containing anionic surfactants
DE19530865A1 (de) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Wirkstoff sowie Mittel zur parenteralen Ernährung
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
NZ520238A (en) * 2000-01-27 2004-04-30 Peros Systemes Technologies In Composition for intestinal delivery
GB0015921D0 (en) * 2000-06-30 2000-08-23 Nat Biolog Standards Board Improvements in or relating to stabilisation of substances
CL2008001640A1 (es) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Uso de hidroxiprolina para preparar una composicion de alemento destinada a promover el crecimiento de un animal, como peces, aves y mamiferos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) * 1985-06-14 1988-09-27 Albion International, Inc. Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
EP0341661A3 (en) * 1988-05-11 1991-05-02 The Du Pont Merck Pharmaceutical Company Peptide-drug compositions containing alpha-aminoboronic acid derivatives
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere

Also Published As

Publication number Publication date
AU3058392A (en) 1993-07-19
FI942938A0 (fi) 1994-06-17
CA2125400A1 (en) 1993-06-24
FI942938L (fi) 1994-06-17
EP0617626A1 (en) 1994-10-05
FI942938A7 (fi) 1994-06-17
WO1993011799A1 (en) 1993-06-24
PT101135A (pt) 1994-03-31
JPH06510796A (ja) 1994-12-01
IL104048A0 (en) 1993-05-13
HU9401824D0 (en) 1994-09-28
ZA929761B (en) 1994-06-17
NO942323L (no) 1994-06-17
MX9207407A (es) 1993-06-01
NO942323D0 (no) 1994-06-17

Similar Documents

Publication Publication Date Title
US5804552A (en) Lipid conjugates of therapeutic peptides and protease inhibitors
Leone-Bay et al. N-acylated. Alpha.-amino acids as novel oral delivery agents for proteins
RU2060998C1 (ru) Способ получения пептидов, пептиды, иммуномодулирующая композиция и способ регуляции недостаточной или избыточной функции т-клеток у пациента
EP0134479B1 (de) Modifizierte Protease-Inhibitoren, Verfahren zu ihrer Herstellung und daraus bereitete pharmazeutische Mittel
EP1560590B1 (en) Synthetic complementary peptides and ophthalmologic uses thereof
Matthews Protein absorption
JPH02115130A (ja) 経鼻用カルシトニン製剤
GB2251435A (en) Opioid peptides derived from wheat proteins
JP2805194B2 (ja) 血中トリグリセリド濃度上昇抑制ペプチド及び当該ペプチドを有効成分として含む血中トリグリセリド濃度上昇抑制剤
JPH0680076B2 (ja) 酸−プロテア−ゼ抑制ペプチド誘導体
US5189016A (en) Nutrient compositions containing peptides and method for administering the same
JP3068656B2 (ja) 新規なペプチド及びアンジオテンシン変換酵素阻害ペプチド並びにそれらを含有する経口摂食組成物
AU2001280052B2 (en) Pharmaceutical composition comprising an analgesic peptide
HUT69785A (en) Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enzymatic inactivation
AU2001280052A1 (en) Pharmaceutical composition comprising an analgesic peptide
WO1995000169A1 (en) Medical use of stem bromelain protease
Hosny et al. Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate
US6153592A (en) Enhancing the bioavailability of proteolytically labile therapeutic agents
JP2004010569A (ja) コレシシトキニン分泌促進活性を有するアルギニン含有ペプチドおよびこれを含有する食品。
LEE Peptidase activities in absorptive mucosae
JPH06220090A (ja) ポリペプチド
US20250375416A1 (en) Serine protease inhibitory effects of health supplements in human cancerous cell lines
JP2003128694A (ja) アンジオテンシン変換酵素阻害ペプチド
AU2014203176B2 (en) Transdermal delivery systems of peptides and related compounds
JPS62501291A (ja) 精製セリンプロテアーゼインヒビターおよびこれを含有する医薬組成物

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal